Liquid Biopsies 2019 is organized by SelectBio and will be held from Mar 27 - 29, 2019 at Coronado Island Marriott Resort & Spa, Coronado, California, United States of America.
Conference Description:
This conference focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring and minimal residual disease detection.
Topics:
• Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
• Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
?Emerging Technologies and Emerging Companies Showcase
?Technology Platforms for Interrogation
• Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
• Microfluidics Platforms for Diagnostics Development
• US vs. EU vs. Asia/Pacific Regulatory Landscape for Liquid Biopsies
Additional details will be posted as soon as they are available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved